Can B Corp. (OTCQB: CANB) Launches In Conjunction With Dr. Karl Zarse ImmuneX2, A Physician-Developed Proprietary Super Immune Boosting AM/PM Supplement Designed To Optimize The Health System Of Users Before Needed; Shipments Start In November
Can B Corp. (OTCQB: CANB), a diversified health and wellness developing company, announced yesterday it will begin shipping in November ImmuneX2 a physician-developed proprietary super immune boosting AM/PM supplement. It is designed to optimize the health system of users before needed. Developed in collaboration with Dr. Karl Zarse, ImmuneX2 offers AM/PM dosing for consistent serum concentration.
The CBD market has drawn intense interest from media companies. stockmarketpress.com features specialized coverage of related stocks such as Can B Corp. (OTCQB: CANB), Aurora Cannabis Inc. (NYSE:ACB) (TSX: ACB), Cronos Group (NASDAQ: CRON), Canopy Growth Corp. (NYSE: CGC), Charlotte’s Web (CSE: CWBHF), INSYS Therapeutics, Inc. (NASDAQ: INSY), cbdMD (NYSE: YCBD), Joy Organics (NASDAQ: JOYG),, GW Pharmaceuticals (NASDAQ: GWPH) and Supreme Cannabis Co. (OTC: SPRWF).
Can B Corp. (OTCQB: CANB) Launches In Conjunction With Dr. Karl Zarse ImmuneX2, A Physician-Developed Proprietary Super Immune Boosting AM/PM Supplement Designed To Optimize The Health System Of Users Before Needed; Shipments Start In November
ImmuneX2 was developed in collaboration with Dr. Karl Zarse offers free member real-time education. The physician-developed immunity optimization formula offers both innate and adaptive immune functionality targeted with a proprietary customer blend focused on immune system optimization. Can B Corp. (OTCQB: CANB) Launches In Conjunction With Dr. Karl Zarse ImmuneX2, A Physician-Developed Proprietary Super Immune Boosting AM/PM Supplement Designed To Optimize The Health System Of Users Before Needed; Shipments Start In November
Marco Alfonsi, CAN B Corp.’s (OTCQB: CANB) CEO, said, “We are really excited to have this opportunity to bring to market such a unique, powerful, and needed product such as ImmuneX2. Dr. Zarse states that he and his team have come up with a supercharged proprietary immunity blend. Our fulfillment operations in Lacey, Washington, just outside of Seattle, are ramping up preparation for expected substantial production. Our current and expanding distribution network, especially the medical offices and doctors, are prime candidates to start accepting shipments by the end of November.”
Dr. Karl Zarse, stated, “This collaboration and strategy have made my dream come true in having an immune-boosting system widely available to the public. I think it’s going to be a game-changer as to why keeping an optimized immune system is so important in order to live a healthy lifestyle. I look forward to working closely with Can B in producing ImmuneX2 and distributing it through their existing sales channels and ever-expanding network.” Can B Corp. (OTCQB: CANB) Launches In Conjunction With Dr. Karl Zarse ImmuneX2, A Physician-Developed Proprietary Super Immune Boosting AM/PM Supplement Designed To Optimize The Health System Of Users Before Needed; Shipments Start In November.
Dr. Karl Zarse’s Credentials
Dr. Karl Zarse is founding member of Idaho Spine And Pain and certified by the American Board of the Interventional Pain Physicians. Refer to website of the Idaho Spine And Pain to learn more.
Multi-Channel Multi-Channel Marketing Strategy A Plus For Can B Corp. (OTCQB: CANB)
Can B Corp. (OTCQB: CANB) markets products such as drops/tinctures, oils, creams, moisturizers, chews, isolate, gel caps, concentrates and more. Its diverse proprietary product lines are available under license, private label and branded labels. Can B Corp. (OTCQB: CANB) is a health and wellness company providing CBD products under the brands Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. It markets to multi-channels including medical offices, doctor’s offices, retailers, online and direct.
Source: Stock Market Press
Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.
Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.
Contact:
Stock Market Press
110 Wall St.
New York, NY 10005 info@stockmarketpress.com Safe Harbor Statement:
Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.
See Stock Market Press disclaimer: https://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press
